China News Service, July 9th, on the evening of the 9th, Kangmei Pharmaceutical announced that it received a notice from the family of the company's actual controller, Ma Xingtian, that Ma Xingtian had been compelled by public security organs for alleged violations of disclosure and non-disclosure of important information. According to the announcement, Ma Xingtian has not held any position in Kangmei Pharmaceutical since May 2020. According to the China Securities Regulatory Commission, Kangmei Pharmaceutical has inflated operating income of 8.99 billion yuan, 100.32 billion yuan, 8.484 billion yuan, and 1.613 billion yuan in 2016, 2017, 2018 half-year, and 2018 respectively; in 2016, 2017, In the first half of 2018, the monetary funds were increased by 22.549 billion yuan, 29.944 billion yuan and 36.188 billion yuan respectively.